StemCell Institute Inc. (TYO:7096)
Japan
· Delayed Price · Currency is JPY 1,070.00
+14.00 (1.33%)
Jun 16, 2025, 3:30 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 10.96 billion as of June 16, 2025. Its market cap has decreased by -39.58% in one year.
Market Cap
10.96B
Enterprise Value
8.28B
Revenue
2.68B
Ranking
n/a
PE Ratio
28.46
Stock Price
1,070.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 10.96B, a decrease of -48.18%. That is a compound annual growth rate of -15.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 10.96B | -16.99% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.27T |
| Takeda Pharmaceutical Company | 6,792.43B |
| Daiichi Sankyo Company | 6,565.02B |
| HOYA Corporation | 5,710.12B |
| Terumo | 3,848.15B |
| Otsuka Holdings | 3,828.90B |
| Astellas Pharma | 2,485.56B |
| Olympus | 2,142.84B |